ArticleEuropean heart journal. Case reports2026
A coronary event without coronary artery disease: the hidden role of inherited thrombophilia-a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: ST-segment elevation myocardial infarction (STEMI) in young patients without traditional cardiovascular risk factors requires evaluation beyond atherosclerotic disease. Inherited thrombophilia and cancer-related prothrombotic states represent important alternative aetiologies. Case summary: A 42-year-old man presented with an acute inferior STEMI. Coronary angiography demonstrated thrombotic occlusion of the proximal right coronary artery, treated with drug-eluting stent implantation. The patient had no cardiovascular risk factors. His medical history was significant for seminomatous testicular cancer treated with orchiectomy and cisplatin-based chemotherapy 10 months prior. Laboratory and imaging findings did not support atherosclerotic disease, and tumour markers were within normal limits. Given the absence of conventional risk factors, further evaluation was undertaken. Genetic testing revealed inherited thrombophilia. Following multidisciplinary consultation, antithrombotic therapy was optimized by adding rivaroxaban and adjusting antiplatelet therapy. At 1-year follow-up, the patient remained asymptomatic with no recurrent thrombotic events. Discussion: This case highlights the importance of a systematic and personalized diagnostic approach in young STEMI patients without evident coronary artery disease. Although inherited thrombophilia was considered a plausible underlying cause of coronary thrombosis in this case, the coexistence of prior malignancy and cisplatin-based chemotherapy may have further amplified the patient's prothrombotic state. Therefore, it is probable that multiple pathogenic mechanisms coexisted and contributed to the development of coronary thrombosis. While typically linked to venous thromboembolism, inherited thrombophilia may also contribute to arterial thrombosis in selected patients, with important implications for long-term management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.